Grown Rogue International Inc. (GRIN.CN)
CAD 0.66
(-1.49%)
CAD 0.66
(-1.49%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 21.82 Million USD | 31.51% |
| 2022 | 17.75 Million USD | 89.34% |
| 2021 | 9.37 Million USD | 121.22% |
| 2020 | 4.23 Million USD | 8.02% |
| 2019 | 3.92 Million USD | 103.14% |
| 2018 | 1.93 Million USD | 1138.02% |
| 2017 | 156.06 Thousand USD | 0.0% |
| 2016 | - USD | -100.0% |
| 2015 | 40.06 Thousand USD | -33.0% |
| 2014 | 59.8 Thousand USD | 109.71% |
| 2013 | 28.51 Thousand USD | -27.79% |
| 2012 | 39.49 Thousand USD | -46.14% |
| 2011 | 73.32 Thousand USD | -26.21% |
| 2010 | 99.37 Thousand USD | 76.82% |
| 2009 | 56.19 Thousand USD | 20345.27% |
| 2008 | 274.88 USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 6.65 Million USD | 0.0% |
| 2024 Q3 | 7.71 Million USD | 15.98% |
| 2023 Q3 | 6.29 Million USD | 4.85% |
| 2023 FY | 23.35 Million USD | 31.51% |
| 2023 Q2 | 6 Million USD | 32.54% |
| 2023 Q1 | 4.53 Million USD | -10.69% |
| 2023 Q4 | 6.52 Million USD | 3.6% |
| 2022 Q1 | 3.73 Million USD | -0.73% |
| 2022 Q3 | 4.25 Million USD | -9.54% |
| 2022 Q4 | 5.07 Million USD | 19.31% |
| 2022 Q2 | 4.7 Million USD | 25.92% |
| 2022 FY | 17.75 Million USD | 89.34% |
| 2021 Q3 | 3.02 Million USD | 96.89% |
| 2021 FY | 9.37 Million USD | 121.22% |
| 2021 Q4 | 3.76 Million USD | 24.14% |
| 2021 Q1 | 1.05 Million USD | -0.52% |
| 2021 Q2 | 1.53 Million USD | 46.35% |
| 2020 FY | 4.23 Million USD | 8.02% |
| 2020 Q4 | 1.05 Million USD | 16.89% |
| 2020 Q2 | 1.17 Million USD | 5.99% |
| 2020 Q3 | 903.99 Thousand USD | -22.91% |
| 2020 Q1 | 1.1 Million USD | 156.31% |
| 2019 Q2 | 1.88 Million USD | 125.95% |
| 2019 Q4 | 431.62 Thousand USD | -44.23% |
| 2019 FY | 3.92 Million USD | 103.14% |
| 2019 Q1 | 834.3 Thousand USD | 5.58% |
| 2019 Q3 | 773.93 Thousand USD | -58.95% |
| 2018 Q3 | 679.9 Thousand CAD | 133.62% |
| 2018 FY | 1.93 Million USD | 1138.02% |
| 2018 Q4 | 790.23 Thousand USD | 16.23% |
| 2018 Q2 | 291.02 Thousand USD | 70.23% |
| 2018 Q1 | 170.96 Thousand USD | 17.72% |
| 2017 Q3 | 13.12 Thousand USD | 292.11% |
| 2017 Q2 | 3346.25 USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 FY | 156.06 Thousand USD | 0.0% |
| 2017 Q4 | 145.22 Thousand USD | 1006.79% |
| 2016 Q3 | - USD | 0.0% |
| 2016 FY | - USD | -100.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q1 | - CAD | -100.0% |
| 2015 Q1 | 9426.38 USD | -20.4% |
| 2015 Q4 | 6703.26 USD | -33.51% |
| 2015 Q3 | 10.08 Thousand USD | 5.25% |
| 2015 Q2 | 9578.45 USD | 1.61% |
| 2015 FY | 40.06 Thousand USD | -33.0% |
| 2014 Q1 | 8766.38 USD | -37.56% |
| 2014 FY | 59.8 Thousand USD | 109.71% |
| 2014 Q2 | 20.38 Thousand USD | 132.49% |
| 2014 Q3 | 17.89 Thousand USD | -12.21% |
| 2014 Q4 | 11.84 Thousand USD | -33.82% |
| 2013 Q1 | 9559.95 USD | -4.06% |
| 2013 FY | 28.51 Thousand USD | -27.79% |
| 2013 Q4 | 14.04 Thousand USD | 2995.85% |
| 2013 Q3 | -484.83 USD | -104.9% |
| 2013 Q2 | 9902.20 USD | 3.58% |
| 2012 Q3 | 7027.02 USD | -45.45% |
| 2012 FY | 39.49 Thousand USD | -46.14% |
| 2012 Q2 | 12.88 Thousand USD | 52.91% |
| 2012 Q1 | 8424.61 USD | -26.29% |
| 2012 Q4 | 9964.26 USD | 41.8% |
| 2011 Q3 | 18.19 Thousand USD | -0.31% |
| 2011 Q4 | 11.43 Thousand USD | -37.17% |
| 2011 Q1 | 19.36 Thousand USD | 15.44% |
| 2011 FY | 73.32 Thousand USD | -26.21% |
| 2011 Q2 | 18.24 Thousand USD | -5.75% |
| 2010 Q3 | 21.64 Thousand USD | 18.39% |
| 2010 Q2 | 18.28 Thousand USD | -47.29% |
| 2010 Q1 | 34.68 Thousand USD | 39.73% |
| 2010 FY | 99.37 Thousand USD | 76.82% |
| 2010 Q4 | 16.77 Thousand USD | -22.52% |
| 2009 Q4 | 24.82 Thousand USD | 18.64% |
| 2009 Q1 | 204.80 USD | 291.29% |
| 2009 FY | 56.19 Thousand USD | 20345.27% |
| 2009 Q3 | 20.92 Thousand USD | -30.45% |
| 2009 Q2 | 30.08 Thousand USD | 14591.62% |
| 2008 FY | 274.88 USD | 0.0% |
| 2008 Q4 | 52.34 USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aion Therapeutic Inc. | 367.47 Thousand CAD | -5840.073% |
| Ayurcann Holdings Corp. | 25.15 Million CAD | 13.233% |
| Blueberries Medical Corp. | 288.27 Thousand CAD | -7472.196% |
| The BC Bud Corporation | 61.48 Thousand CAD | -35403.923% |
| BioNxt Solutions Inc. | 372.24 Thousand CAD | -5763.989% |
| CordovaCann Corp. | 13.59 Million CAD | -60.566% |
| Christina Lake Cannabis Corp. | 11.77 Million CAD | -85.306% |
| Captor Capital Corp. | 36.76 Million CAD | 40.629% |
| City View Green Holdings Inc. | 8582.00 CAD | -254252.389% |
| 1CM Inc. | 35.34 Million CAD | 38.235% |
| Global Hemp Group Inc. | - CAD | -Infinity% |
| Greenway Greenhouse Cannabis Corporation | 5.23 Million CAD | -317.356% |
| IM Cannabis Corp. | 48.8 Million CAD | 55.273% |
| Lobe Sciences Ltd. | 840.53 Thousand CAD | -2496.983% |
| Maple Leaf Green World Inc. | - CAD | -Infinity% |
| Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -36280.87% |
| Nextleaf Solutions Ltd. | 8.17 Million CAD | -166.865% |
| Ovation Science Inc. | 61.93 Thousand CAD | -35144.812% |
| Pharmadrug Inc. | - CAD | -Infinity% |
| Captiva Verde Wellness Corp. | 174.78 Thousand CAD | -12388.642% |
| RAMM Pharma Corp. | 5.06 Million CAD | -330.946% |
| RIV Capital Inc. | 7.48 Million CAD | -191.511% |
| Revive Therapeutics Ltd. | - CAD | -Infinity% |
| Red White & Bloom Brands Inc. | 88.33 Million CAD | 75.288% |
| SLANG Worldwide Inc. | 35.68 Million CAD | 38.825% |
| 1933 Industries Inc. | 18.27 Million CAD | -19.456% |
| Red Light Holland Corp. | 4.75 Million CAD | -359.356% |
| Top Strike Resources Corp. | 13.32 Million CAD | -63.788% |
| Xebra Brands Ltd. | 106.85 Thousand CAD | -20328.171% |
| Adastra Holdings Ltd. | 22.22 Million CAD | 1.774% |